About
Ken Horne is a U.S.-based biotech investor and executive who serves as Managing Partner of AN Venture Partners, a Japan-focused biotech venture firm. His prior roles include chairing RDiscovery, helping start companies such as Capacity Bio, Typewriter Therapeutics, and Viage Therapeutics, and earlier operating roles at Teon Therapeutics, Symic Bio, and Aline Aesthetics. He also serves in advisory and board capacities, including appointment to the AMED Advisory Board in Japan.
Areas of interest
biotechdrug developmenthealthcare investingJapan-US biotech translationventure creationneurologyRNA therapeuticscardiopulmonary diseasemitochondrial biology